Northern Trust »

Celldex Therapeutics shares owned by Northern Trust

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Northern Trust from 13F filings

Historical chart of Northern Trust investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Northern Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Northern Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 563k 34.00
2024-03-31 $23M 554k 41.97
2023-09-30 $13M 474k 27.52
2023-06-30 $17M 488k 33.93
2023-03-31 $17M 481k 35.98
2022-12-31 $19M 435k 44.57
2022-09-30 $12M 422k 28.10
2022-06-30 $11M 424k 26.97
2022-03-31 $15M 440k 34.06
2021-12-31 $18M 464k 38.65
2021-09-30 $25M 459k 53.99
2021-06-30 $14M 412k 33.43
2021-03-31 $2.2M 107k 20.69
2020-12-31 $1.7M 95k 17.52
2020-09-30 $1.3M 88k 15.00
2020-06-30 $745k 57k 12.99
2020-03-31 $45k 34k 1.31
2019-12-31 $91k 35k 2.62
2019-09-30 $61k 29k 2.06
2019-06-30 $75k 29k 2.60
2019-03-31 $146k 28k 5.19